T. Rowe Price Investment Management’s Guardant Health GH Stock Holding History

T. Rowe Price Investment Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Sell	17,936 -737,771	-98%	-$80.2M	﹤0.01%	677
2026 Q1	$69.8M	Buy	+755,707	New	+$75.9M	0.05%	301
2024 Q1	–	Sell	-1,010,326	Closed	-$27.3M	–	636
2023 Q4	$27.3M	Sell	1,010,326 -482,774	-32%	-$12.7M	0.02%	461
2023 Q3	$44.3M	Hold	1,493,100	–	–	0.03%	379
2023 Q2	$53.5M	Buy	+1,493,100	New	+$42.9M	0.04%	368

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

T. Rowe Price Investment Management's GH Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Guardant Health (GH) stake by 98% in Q2 2026, selling an estimated $80.2M and leaving 17,936 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #677.

T. Rowe Price Investment Management first reported a position in GH in Q2 2023 and has held it in 5 quarters since. The position peaked at $69.8M in Q1 2026. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.

T. Rowe Price Investment Management held 17,936 shares of Guardant Health worth $2.69M as of Q2 2026.
T. Rowe Price Investment Management sold 737,771 Guardant Health shares in Q2 2026, an estimated $80.2M.
Guardant Health made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #677 holding.
T. Rowe Price Investment Management first reported a position in Guardant Health in Q2 2023 and has held it in 5 quarters since.
T. Rowe Price Investment Management's Guardant Health position peaked at $69.8M in Q1 2026.
596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.